SEC Form 4 · accession 0001554795-16-000762
IRIS BIOTECHNOLOGIES INC · IRSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simon Chin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jun 23, 2016
Accepted (ET)
Jul 20, 2016 · 9:18 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396238
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 23, 2016 | G | 50,000 | $0.00 | D | 11,366,510 | D | |
| Common Stock | Jul 19, 2016 | J | 1,041,667 | $0.12 | A | 12,408,177 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
$125,000 in salary paid in stock.